Transmembrane protein 16A/anoctamin 1 inhibitor T16A<sub>inh</sub>-A01 reversed monocrotaline-induced rat pulmonary arterial hypertension.

Authors:
Xie J; Liu W; Lv W; Han X; Kong Q and 5 more

Journal:
Pulm Circ

Publication Year: 2020

DOI:
10.1177/2045894020946670

PMCID:
PMC8826276

PMID:
35154665

View on PubMed View on PMC View Publisher
Journal Information

Journal Title: Pulm Circ

Detailed journal information not available.

Publication Details

Subject Category: Respiratory System

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest The author(s) declare that there is no conflict of interest."

Evidence found in paper:

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is supported by National Key R&D Program of China (2016YFC1000808), the National Natural Science Foundation of China (81470926), Shandong Province Natural Science Foundation (ZR2019MH110), and Bureau Science and Technology of Qingdao (16-6-2-16-nsh, 19-6-1-19-nsh)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025